Atom Investors LP Assembly Biosciences, Inc. Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.33 - $6.63 $1.05 Million - $1.61 Million	-243,079 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.87 - $17.29 $507,303 - $1.8 Million	104,169 Added 74.99%	243,079 $1.47 Million
Q3 2020 Nov 13, 2020	SELL	$15.08 - $27.04 $90,902 - $162,997	-6,028 Reduced 4.16%	138,910 $2.28 Million
Q2 2020 Aug 14, 2020	BUY	$14.57 - $23.96 $144,782 - $238,090	9,937 Added 7.36%	144,938 $3.38 Million
Q1 2020 May 15, 2020	BUY	$10.27 - $21.23 $1.39 Million - $2.87 Million	135,001 New	135,001 $2 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.